Delivery Order SPE2DB24D2013-SPE2DB24FCHLF

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The $11,373.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the supply of HUMIRA PEN 40 MG/0.8 MLS to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,847.20 firm fixed price delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp. for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The $11,533.16 firm fixed-price delivery order has a completion date of May 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,770.89 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The $5,769.18 firm fixed-price delivery order contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides HUMIRA(CF) PEN 40 MG/0.4 MLS medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $18,974.56 firm-fixed price delivery order has a completion date of September 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a range of medical...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medical products to the Defense Logistics Agency (DLA). The $44,455.36 firm fixed-price delivery order has a completion date of March 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a firm-fixed price delivery order valued at $3,398.85. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of July 7, 2025 and was awarded on July 3, 2025. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a significant...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The $6,210.51 firm-fixed-price contract has a period of performance through September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,323.32 delivery order is for the supply of HUMIRA (CF) PEN 40 MG/0.4 MLS, a specialty medication. The contract has a firm fixed price and an ultimate completion date of September 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB24FCHLF
    Delivery Order

The federal contract award is to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to provide the drug HUMIRA (CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA). The $10,042.97 firm-fixed-price delivery order has an ultimate completion date of August 20, 2024 and was awarded on August 19, 2024. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 11/18/24, 9:20 AM